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Objectives. Using opinion data from experts, we examined the context of the argument
for mandatory testing of psychiatric patients.
Methods. Vignettes were distributed to experts on HIV and mental illness. Respon-
dents were asked to provide appropriateness ratings for different hypothetical clinical
decisions regarding HIV management.
Results. Respondents were reluctant to impose testing without informed consent in
most circumstances. The presence of risk factors or danger to another increased ap-
propriateness ratings modestly.
Conclusions. Despite experts’ tendency to emphasize individual rights, public reluc-
tance to mandate testing is unlikely to extend to people with serious mental illness. No
argument for mandatory testing can be persuasive if improved voluntary testing can
achieve adequate detection rates. Voluntary testing protocols should be studied to de-
termine which successfully identify infected individuals. (Am J Public Health. 2002;92:
1931–1939)
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Interest in the now well-documented spread
of HIV among those with serious mental ill-
ness was largely confined to mental health
professionals until 2 events in the late
1990s called attention to this issue in
broader, policy-related discussions. The first
was the 1997 passage by the New Jersey
legislature of a bill that required all patients
admitted to state psychiatric hospitals to be
tested for HIV, even if they did not con-
sent.1–3 Had a last-minute veto by a moder-
ate Republican governor not forced legisla-
tors to include a requirement that patients
give informed consent,4 HIV testing would
have been mandatory for all new admis-
sions throughout the state psychiatric hospi-
tal system, setting a precedent for other
states. The second event was the highly
publicized arrest, in the fall of 1997, of
Nushawn Williams, an HIV-positive man
who was believed to have infected scores of
women in Chautauqua County, New York,
and New York City. Shortly after Williams
was arrested on a drug charge, reports indi-
cated that he had previously been diag-
nosed with schizophrenia. A New York Post
columnist, concerned that a claim of mental
disability might be used to evade legal ac-
countability, complained, in an inflamma-
tory lead, that “It’s crazy to put this vulture
in a cuckoo’s nest.”5
These 2 events highlight how public atten-
tion to the spread of HIV in a population not
typically considered in this context can chal-
lenge previously established public attitudes
and public policy. The working policy consen-
sus developed in the 1980s carried an im-
plicit image of AIDS patients, their motiva-
tions, and their likely responses to specific
policies. Mandatory HIV testing was initially
rejected as unworkable, politically insupport-
able, and ethically problematic. As changes in
this implicit image begin to reflect new epide-
miologic and therapeutic realities, the implica-
tions of older policies are not always clear. It
remains to be seen whether HIV testing may
be mandated for some people with serious
mental illness. We examine the debate on this
issue.
Definitions of serious mental illness
vary,6,7 but they typically incorporate infor-
mation on diagnosis, disability, and illness
duration. The category usually includes
many with schizophrenia and bipolar disor-
der, as well as other conditions, such as re-
current major depression and personality
disorders, when these produce high levels of
impairment.8 While many of those falling
into this category have received inpatient
psychiatric care at some point, all but the
most severely ill spend most of their time in
the community, where they rely on outpa-
tient settings for services. Since the New Jer-
sey legislation targeted inpatient admis-
sions—and, as a practical matter, because
blood is routinely drawn on admission, and
mandatory testing seems more likely to be
adopted in inpatient rather than outpatient
settings—we primarily focus on hospitalized
patients, mentioning outpatient care only
when it seems relevant.
Public rhetoric over mandatory testing
has had an alarmist cast, but the ethical is-
sues raised by the spread of HIV among the
seriously mentally ill are by no means sim-
ple. They have been debated within the pro-
fession for over a decade.9–19 Without an ef-
fective treatment to offer in the first years of
the epidemic, some experts felt that the ben-
efits of early detection and treatment were
insufficient to justify the intrusiveness of
testing and the distress it caused.15 Counsel-
ing and confidentiality protections in the
mental health system were thought to be so
inadequate that knowledge of one’s HIV
status was arguably more burdensome than
beneficial.20 Nevertheless, advocates for
mandatory testing argued that knowledge of
a patient’s HIV status was crucial for differ-
ential diagnosis of some psychiatric com-
plaints,10 and that patients with severe men-
tal illness were often unaware of their HIV
risk and serostatus and thus were unlikely
to seek voluntary testing.21 It was also pro-
posed that an exception to the AIDS confi-
dentiality rule be made for psychiatric pa-
tients deemed dangerous.11
Recent changes in the logic and prevailing
discourse of prevention provide an important
context for our examination of this issue. One
early and influential prevention paradigm fo-
cused efforts on modifying the behavior of
the entire population. Any less universal focus
(on, for example, “risk groups”) was viewed as
undesirable because it was liable to under-
mine the message that each individual was re-
sponsible for his or her own protection. In the
words of a popular expression of the period,
“AIDS doesn’t discriminate.” Targeted preven-
tion, it was held, might also foster an “us–
them” attitude by the public, weakening an al-
ready fragile social solidarity.22
The case for targeted prevention is no
longer viewed with such suspicion. In 1996,
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between 37% and 64% of US adults with
HIV were not receiving appropriate care, ei-
ther because they were unaware of infection
or because they had not accessed services.23
Yet a review of applications for Centers for
Disease Control and Prevention (CDC) pre-
vention funds found that most did not name
people with HIV as a priority population for
prevention.24 In this context, efforts to de-
crease risk behavior by people with HIV/
AIDS have acquired increased legiti-
macy.25–28 This new approach emphasizes
the need to increase the number of people
who know their serostatus among those al-
ready infected, who can then be brought
into care and recruited as partners in pre-
vention. This new framework has been put
into action with the CDC’s SAFE (Serostatus
Approach to Fighting the Epidemic) initia-
tive24 and its “Know Now” media campaign
to encourage testing.28
Today, early detection of HIV infection is
widely encouraged.29 New testing proce-
dures may reduce the stress and inconven-
ience of HIV testing, since it is now possible
to use urine or saliva rather than blood, and
provide initial information on test results al-
most immediately (although it is still neces-
sary to run a Western blot test to confirm a
positive test, which takes time).30 The prom-
ise of life-extending treatments can now be
weighed against the adversities of testing.
Given the evidence that, among those with
serious mental illness, behaviors that in-
crease the risk of HIV transmission are com-
paratively common,31,32 documented rates of
HIV infection are elevated, and HIV testing
practices are inadequate, some action is war-
ranted to increase rates of HIV testing. In
this study, we discuss ethical and policy is-
sues raised by the use of mandatory testing
to increase testing rates, examining testing
policies in the context of the historical and
contemporary social context in which they
have arisen.
PRINCIPLES AND POLICYMAKING
Various abstract ethical concepts have
played a role in US AIDS policy, but, as
Bayer describes in Private Acts, Social Conse-
quences, the balancing of these principles was
influenced by cultural, political, and social
forces as well.33 During the 1980s, main-
stream AIDS policy coalesced around a “vol-
untarist consensus” forged from a combina-
tion of principled and practical considerations.
As a matter of principle, the tradition of civil
liberty runs deep in the United States. Nu-
merous institutions and practices express the
high regard held for values such as noninter-
ference and autonomy, which arise from re-
spect for individual privacy. Compulsory ef-
forts to identify infected individuals were
widely rejected.34 As a practical matter, be-
cause most acts of viral transmission take
place in private settings, state surveillance
and control are exceedingly difficult. Rather
than attempt to police private acts, require
HIV testing, or quarantine the infected, the
voluntarist view argued that policy should
safeguard confidentiality, strengthen antidis-
crimination laws, and rely on education and
persuasion to promote behavior change and
encourage testing.35–37 The generally moder-
ate approach and comparatively strict confi-
dentiality regulations in effect until recently
in New York and New Jersey largely embod-
ied voluntarist principles, but they were cre-
ated with little consideration of HIV in spe-




Medical care for patients with the most se-
rious psychiatric conditions can be challeng-
ing and has historically suffered from neglect,
with the result that many treatable conditions
go unrecognized, leading to elevated mortal-
ity rates.38,39 In the 1980s, psychiatric atten-
tion was initially focused on helping infected
patients deal with the medical and psychiatric
accompaniments of infection and managing
the various medical and legal dilemmas
raised. The risk of HIV infection among peo-
ple with serious mental illness was not imme-
diately apparent.
More than 40 cases of HIV disease had
been identified in New York’s state psychiat-
ric hospital system by 1987,40 but sustained
interest in infection rates among those with
serious mental illness arose comparatively re-
cently. Published estimates based on studies
in psychiatric settings suggest that, at least in
high-prevalence areas like New York City
where most data have been collected, the
rate of HIV infection among people with se-
vere mental illness ranges from 4.0% to
22.9%.41 One New York City unit for pa-
tients with combined substance abuse and
psychiatric illness reported an infection rate
of 23%.42 Using figures from published stud-
ies, city officials in New York City estimated
in 1996 that between 1130 and 1189 known
HIV-positive individuals with serious mental
illness were being served in the mental
health system.43
Studies conducted in psychiatric settings
in other areas reported lower, but still trou-
bling, rates.41 A recent study that included
outpatients and inpatients from a mixture of
high-prevalence urban areas, smaller metro-
politan areas, and rural settings found a
lower infection rate (3.1%) but noted that
this rate was still 8 times that of the general
population.44
Few seroprevalence data exist on large
populations. Among HIV-positive Medicaid
recipients in New Jersey, 5.7% are diag-
nosed with schizophrenia and 6.8% with
major affective disorder.45 Blank and col-
leagues compared Medicaid and welfare re-
cipients with and without serious mental ill-
ness and found that, after they controlled
for age, sex, race, and time on welfare,
schizophrenia and affective disorder signifi-
cantly increased the odds of an individual
being HIV positive.46 On the basis of data
from emergency room visits and hospital
discharges in South Carolina, patients diag-
nosed with a mental illness are 1.44 times
more likely to have HIV/AIDS than those
not so diagnosed.47 Inasmuch as Medicaid
claims and hospital discharges capture only
cases in the treatment system, these figures
do not count patients who may have a
major psychiatric illness but do not receive
treatments that produce claims or discharge
records.
Ironically, despite the high prevalence of
HIV in New York State, the evidence leaves
little doubt that statewide efforts to promote
testing for psychiatric patients have been
grossly inadequate. Using data collected
from visits to half the general hospital psy-
chiatric units in the state, Walkup and col-
leagues found that 70% of the units urged
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testing for only “a few” or “almost none” of
their patients.48 A 1995 statewide survey of
licensed outpatient mental health facilities
in New York State found that fewer than
half the sites responding had staff trained to
provide HIV counseling and testing.49 A
similar survey in 1997 found that fewer
than one third of sites reported that HIV
risk assessment was routine.50 Two decades
into the epidemic, data collected from men-
tal health agencies between March 2000
and January 2001 indicate that, despite
gains made from focused efforts to increase




Awareness of infection is a practical pre-
condition to treatment in almost all circum-
stances. Grassi has warned that many HIV-
positive psychiatric patients are unaware of
their status.52 The limited data available
confirm this fear.53 Even in New York State,
where risk screening interviews are man-
dated, staff fail to identify as many as two
thirds to three quarters of HIV-infected pa-
tients in some settings.42,54–56 Some blame
can be assigned to a “passive” approach to
HIV testing derived from a diagnostic test
paradigm, in which “ordering the test is ap-
propriate only if test results are positive at
some regular frequency.”57(p1995) In many
psychiatric settings, HIV testing is provided
only when it is considered appropriate for
an individual patient, either when it has
been requested by the patient or urged by
staff on the basis of information about risk
behavior.
Routine clinical judgments about when to
order testing are highly fallible. As in other
medical settings,58 information on high-risk
behavior is frequently missed by psychiatric
staff 39,59 and commonly goes unrecorded in
the charts of HIV-positive inpatients.60 Rou-
tine intake questions may not provide
enough information to alert clinicians to sug-
gest testing. Only about 1% of psychiatric
patients in a New York City study reported
intravenous drug use in the past 6 months,
yet detailed questioning found that 1 in 5
had used intravenous drugs since the start of
the US HIV epidemic in 1978.61 A study of
inpatients with schizophrenia in 4 New York
City hospitals found that fewer than 1 in 5
had recently been tested for HIV; even the
majority of injection drug users had not re-
cently been tested.62 
Inaccurate stereotypes about the men-
tally ill may cause staff to underestimate
risk. Even experienced clinicians may some-
times mistakenly view people with serious
mental illness as asexual. While it is true
that many seriously mentally ill people re-
port having sex infrequently, studies indi-
cate that the sexual intercourse that does
occur is often unprotected, involves multi-
ple partners, or both.63,64 Marriage and
long-term relationships are comparatively
rare.65 Many of those who are sexually ac-
tive meet partners in public places, such as
bars or on the street,66 trade sex for mate-
rial gain, or report a history of sexual con-
tact with an injection drug–using part-
ner.31,67 High rates of sexual victimization
are reported as well.68,69
Screening for risk factors may also suffer
because professionals are reluctant to bring
up HIV with psychiatric patients, often out
of well-meaning concern for the patient’s
welfare. They may overestimate the anxiety
caused by taking a sexual history70 or fear
that discussing emotionally charged issues,
such as sexual behavior and HIV, may
worsen psychiatric symptoms. They may as-
sume that patients’ sexual histories are unre-
liable and see little point in obtaining them.
Yet there is evidence that patients give reli-
able information and that many welcome the
opportunity to discuss sexual issues.71
Newly admitted inpatients are often consid-
ered too disturbed for testing. However,
workers also fear that, as discharge ap-
proaches, a positive HIV test may increase a
patient’s length of stay or create logistical
problems with posttest notification and coun-
seling if the test result arrives after discharge.
In a time when most inpatient stays are short,
the period during which testing is considered
acceptable becomes short indeed. Commenta-
tors have noted that the current failure to de-
tect HIV relieves overburdened care systems
of a difficult, potentially costly, responsibil-
ity.72 Even when everyone involved is highly
motivated to improve screening, changes that
are likely to increase costs are typically diffi-
cult to implement.
METHODS
In designing a survey to aid in developing
treatment guidelines for patients with comor-
bid HIV and schizophrenia, we included
some questions on the topic of mandatory
HIV testing. We report responses to selected
items in order to shed light on expert opinion
regarding this controversial issue.
Participants
Our approach was to solicit opinions from
nationally known experts. We developed our
list in several ways. We recruited most of our
experts from the list of participants who had
attended a 1996 consensus conference on
HIV and serious mental illness sponsored by
the National Institute of Mental Health. Sub-
jects were initially called by telephone. When
someone could not participate, we asked him
or her to nominate a replacement. In a few
cases, we also sought out experts known to
us through their publications. Of the 28 sub-
jects who agreed to participate, 22 com-
pleted and returned a survey. Over three
quarters (77%) were physicians (mainly psy-
chiatrists). Most had direct clinical experience
with HIV/AIDS (63%) or with serious men-
tal illness (68%). The average length of time
spent working with patients with HIV/AIDS
was 7.5 years. The nonclinicians in the group
either conducted research or worked on pol-
icy issues in the area.
Instrument
We developed our instrument in several
phases. Interviews were conducted with clini-
cians and administrators whose jobs required
them to confront clinical and ethical dilem-
mas associated with the spread of HIV among
people with serious mental illness. On the
basis of the interview data and our experi-
ence, we chose a series of clinical dilemmas
that a clinician working with clients with seri-
ous mental illness might face. The questions
concerned a hypothetical young man with
schizophrenia (Mr A). Respondents were told
he lives in a community residence, is gener-
ally stable when he takes his medication regu-
larly, but has an occasional acute exacerba-
tion of his psychiatric condition. Questions
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Sample Scenarios From Questionnaire Asking Experts on HIV and Mental
Illness to Rate Appropriateness of Different Hypothetical Clinical Decisions
Mr A is a young man with schizophrenia. Between periods of acute exacerbation,
he is generally stable and has been maintained with a low dose of a high-potency an-
tipsychotic (e.g., haloperiodol, 5 mg PO, QD). He lives in a community residence and is
seen monthly for medication checks and case management.
Would you urge Mr A to undergo voluntary HIV testing with informed consent
if he denied HIV risk factors and he has been psychiatrically stable for a long pe-
riod and—
• resides in a community with a high rate of infection?
• resides in a community with a low rate of infection?
Would you be prepared to test Mr A for HIV without his consent if he became
grossly psychotic, was hospitalized, lacked the competence to judge health care
needs, and—
• had no known history of high-risk behavior?
• and had no medical condition noted on physical examination?
• and had a positive VDRL test?
(If Mr A is HIV positive) Now suppose that Mr A has not revealed his diagnosis
to other patients, but during the hospital stay, he reports he had unprotected sex with
another patient, Ms B, who confirms his account. Suppose, too, that Mr A is sexually
preoccupied and will not give assurance that he will avoid sex while on the unit.
Would you—
• isolate Mr A?
• put Mr A on one-to-one observation?
• counsel Ms B that she has been exposed to HIV?
• advise the patient community of rule violation without identifying Mr A and Ms B?
• reinforce rules against sex on the unit?
Note. VDRL=Venereal Disease Research Laboratory; PO=orally; QD=daily.
were reviewed for realism and appropriate-
ness by other clinicians and were modified on
the basis of their comments. Sample scenarios
are included in the box on this page.
Individual questions proposed dilemmas
regarding HIV testing and confidentiality.
1) Questions asked respondents to rate a clin-
ical decision on a scale from 1 (“extremely
appropriate”) to 9 (“extremely inappropriate”)
or to mark an “X” if they were unable to an-
swer because, for example, they lacked the
necessary technical knowledge. Following a
format widely used in previous studies of con-
sensus judgments on clinical issues, choices
rated 2 or 3 were labeled “usually inappropri-
ate,” those rated 7 or 8 “usually appropriate,”
and those rated 4, 5, or 6 “equivocal.”73,74
2) Unreadable and skipped responses were
not counted; the average number of usable
responses was 20.6. Experts not included in
the original sample were asked to comment
on the clinical and policy significance of the
findings.
RESULTS
Experts approached testing with caution
but varied their views on the basis of the
presence of various indicators. Even when
they were told to imagine that Mr A lived in
a community with a high rate of infection,
the mean appropriateness rating for recom-
mending voluntary testing fell short of the
“usually appropriate” standard (mean=5.67,
SD=2.35). To investigate circumstances
under which it might be thought appropriate
to test a patient without informed consent,
respondents were asked if they would be pre-
pared to test Mr A without his consent if he
became grossly psychotic and incompetent to
judge his health care needs. When Mr A had
no known history of high-risk behavior and
no medical problems, the mean rating indi-
cated that forced testing was usually inappro-
priate (mean=2.5, SD=1.73). Ratings rose
into the “equivocal” range when we added ei-
ther a history of high-risk behavior (mean=
5.1, SD=2.6) or the presence of a non-HIV
sexually transmitted disease (mean=5.35,
SD=3.08). When both factors were added
to the vignette, mean ratings reached the
high end of the “equivocal” range (mean=
6.19, SD=3.04).
Respondents were given a space to de-
scribe any other circumstances in which they
might support mandatory testing. One wrote,
“Perhaps if the person had a high probability
of having HIV disease clinically, lacked ca-
pacity to understand actions that could lead
to HIV transmission, [and] regularly has these
behaviors. But this is a complex civil rights vs
public health issue.” A second wrote, “[When]
violent acts on the unit [cause] harm [and]
blood injury results to other patients.” A third
wrote that mandatory testing would be appro-
priate if Mr A sexually assaulted another pa-
tient, in which case prompt combination ther-
apy could be given to the exposed rape
victim, but raised concerns about treating Mr
A himself since he might not comply with a
complicated oral medication regimen, thus in-
creasing the risk of developing a resistant
viral strain.
In the event that Mr A was tested and re-
ceived a positive result, a series of questions
inquired about the circumstances under
which it would be appropriate to disclose
that Mr A was HIV positive without his con-
sent. Disclosure to emergency medical serv-
ices personnel treating Mr A received a mean
rating of 4.62 (SD=3.25), and disclosure to
a nonphysician primary therapist or case
manager received a mean rating of 4.52
(SD=3.2). Disclosure to staff at a residence
considering Mr A for admission was rated as
less appropriate (mean=3.33, SD=2.69)
than disclosure to a primary therapist.
Respondents gave disclosure to a known
sex partner a somewhat higher appropriate-
ness rating of 5.95 (SD=2.58). Disclosure to
family members without consent was consid-
ered inappropriate, with the degree of inap-
propriateness depending on whether Mr A
lived with his family. The mean score was
2.33 (SD=1.74) if he resided with his family
and 1.71 (SD=1.01) if no mention was made
of living with his family.
Some of the main challenges to the volun-
tarist approach to testing among individuals
with serious mental illness concern the risk
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that they might infect others—a topic given
special urgency in clinical settings where phy-
sicians have responsibility for the welfare of
other patients. The questionnaire presented a
scenario in which Mr A is hospitalized and
has not revealed his HIV status to other pa-
tients. He reports to a counselor that he has
already had unprotected sex with a another
patient, Ms B, and refuses to give assurances
that he will not have sex with other patients
while on the unit. Several possible responses
to this situation are presented. The possibility
of isolating Mr A from other patients received
a mean rating of 4.21 (SD=2.68), while the
mean rating for one-to-one observation was
7.32 (SD=1.53). Notifying Ms B that Mr A is
HIV positive fell into the usually appropriate
category (mean=7.53, SD=1.93). The
breach of confidentiality was apparently justi-
fied by the individual risk to Ms B. In con-
trast, notifying the entire patient community
of Mr A’s HIV status was rated as usually in-
appropriate (mean=3.11, SD=2.45). An ap-
proach deemed more appropriate, with a
mean rating of 7.84 (SD=2.22), was to ad-
vise the patient community of high-risk be-
havior on the unit and to reinforce rules
against sex between patients.
DISCUSSION
Overall, our expert respondents showed lit-
tle enthusiasm for testing psychiatric patients
without their consent. Instead, they seem to
approach testing primarily as a clinical—not a
policy—issue, varying their ratings of appro-
priateness in response to changes in clinical
circumstances described in the vignettes. Fur-
ther research might identify the sources of the
attitudes found here. Do they derive primarily
from values associated with professional iden-
tity, or do they draw on personal, political,
and social values? Future work might identify
and analyze differences between values ex-
pressed by these elite professional opinion
makers and administrators or direct care
workers. Also valuable would be evidence
that could clarify how stable these opinions
are and what sorts of events or considerations
might prompt changes.
It is far from clear, however, what role the
opinions of mental health professionals will
play in future policy discussion. Policy
changes can be initiated in various quarters,
some of which assign little weight to profes-
sional opinion. We believe there are several
reasons to anticipate that the tenets of the
voluntarist consensus will be put under strain
by the spread of HIV among the seriously
mentally ill.
First, the very tradition of civil liberty that
provided a foundation for the voluntarist con-
sensus includes a long tradition of allowing—
indeed, sometimes requiring—exceptional
treatment of mentally disabled persons. Civil
procedures allow for involuntary commit-
ment. When someone is judged incompetent
to make a treatment decision, treatment can
be provided over that person’s objection,
using the doctrines of substituted judgment or
best interests. In criminal law, defenses of in-
sanity or diminished capacity are allowed.
These judicial exceptions have generally been
framed as humanitarian, not discriminatory.
While not linked directly to the context of
HIV, several aspects of the current atmos-
phere may indirectly increase the perception
that creating exceptions for people with men-
tal illness is often necessary and reasonable.
Data from the 1996 General Social Survey
indicate that a very high proportion of the
public supports use of legal means to coerce
people with schizophrenia into treatment.75
Recent acts of violence by persons with seri-
ous mental illness have prompted some to
conclude that protection of public safety re-
quires increased authority to restrict the be-
havior of psychotic persons.76–78
Second, as a practical matter, certain types
of surveillance and control are significantly
easier to administer with psychiatric patients
than with the general population. Most major
psychiatric illnesses require medication, and
many people with serious mental illness have
trouble maintaining employment and finding
safe, affordable housing.79,80 For these rea-
sons, many people with serious mental illness
have regular contact with public mental
health and social service workers, who are
socially authorized to inquire about private
matters (e.g., sexual activity, drug use) and
seek to influence behavior. These mental
health and social welfare contacts provide a
ready infrastructure for testing, particularly
since new HIV testing procedures can be
easily implemented by individuals without
specific medical training.30 While it is un-
likely anyone would publicly say that the
practical ease of implementation counts in
favor of mandatory HIV testing, the inability
of opponents to cite practical difficulty as a
reason to oppose mandatory testing would
likely influence the outcome of any policy
discussion.
The circumstances of people with serious
mental illness can be compared with those of
another group considered in the debate over
mandatory testing, pregnant women. With
very few exceptions, these women come into
contact with the medical care system for a de-
livery. New York State now requires that new-
born infants be tested for HIV. Had most preg-
nant women avoided contact with medical
care for delivery, implementation of the pro-
gram would probably have been impossible.
Before implementation, opponents voiced
the fear that the prospect of newborn HIV
testing might make some women reluctant to
seek prenatal or obstetric care—since, in ef-
fect, the test establishes the mother’s serosta-
tus—thus producing an unintended outcome
that undermined public health. Interestingly,
the limited evidence available indicates that
mandatory testing of newborns did not have
the feared effect on health care.81 If access to
psychiatric care is made conditional on HIV
testing, opponents will certainly object that it
may lead to avoidance of care. Given that the
newborn testing program does not seem to
have led to high levels of avoidance of care,
and that there have so far been no highly vis-
ible negative outcomes associated with the
program, less weight may be given to con-
cern about avoidance of care by psychiatric
patients.
Third, comparatively limited political oppo-
sition is likely to result from adoption of an
exception-making strategy for psychiatric pa-
tients. Despite changes in attitudes, serious
psychiatric disability remains highly stigma-
tized.82 People with serious mental illness
rarely have effective informal or institutional
ties to the legal and political resources needed
to influence testing policy. Since psychiatric
advocacy groups have so far paid compara-
tively little attention to HIV, and since AIDS
advocacy groups have paid comparatively lit-
tle attention to people with psychiatric disabil-
ities, there are fewer opportunities to lobby
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legislators, influence provider organizations,
or take part in class action suits.
Fourth, efforts to retain pure voluntarism
have often relied on versions of the camel’s-
nose-in-the-tent argument. They warned that
a limit on the rights of pregnant women, for
example, would eventually open the door to
limitations on the rights of other groups.83
But these arguments may be difficult to apply
to HIV testing for people with serious mental
illness, since the arguments probably over-
state the objective risk entailed by making an
exception for psychiatric patients. They al-
most certainly presume a higher level of so-
cial solidarity concerning this issue than now
exists. Testing has been required for many
groups, such as newborns, prisoners, and
those in the armed services, without wide-
spread protest. It is difficult to imagine the
public fearing that mandatory testing of psy-
chiatric patients would be a harbinger of
more widespread mandatory testing.
The current perception of psychiatry can
be contrasted with its position in the 1980s,
when there were several concrete events that
could reasonably have been interpreted as ef-
forts to use psychiatric authority to create a
back door to quarantine.84 For example, an
Orange County, California, task force was set
up to respond to risky behavior by persons
with HIV infection and required hospitaliza-
tion for several patients whose behavior
seemed to have been associated with severe
psychiatric illness.85 Other actions repre-
sented a more unambiguous effort to stretch
traditional psychiatric authority to cover situa-
tions in which behavioral control was desired
but recognizable psychiatric disorder played
little role. Psychiatrist Paul Applebaum agreed
with the then-current American Psychiatric
Association guidelines in questioning whether
psychiatric facilities ought to be used for the
detention of HIV-infected patients, but he ar-
gued that an HIV-infected person’s unwilling-
ness to desist from risky behavior could con-
stitute legitimate grounds for involuntary
confinement to a psychiatric facility.9 In a case
cited by Bayer,84 a probate judge in Alabama
relied on the authority of the state’s mental
health law to commit a male patient to a state
psychiatric hospital to control HIV transmis-
sion–related behavior. In another instance, a
Florida judge, responding to a petition by the
state’s Department of Health and Rehabilita-
tive Services, ordered an adolescent confined
to a psychiatric ward as a threat to public
health. Bayer notes the unusually explicit link
between social control and a psychiatric con-
ceptualization of recalcitrant risky behavior
found in a similar approach taken by Indiana,
which public health officials characterized as
“non-punitive.”84(p1474)
These efforts to extend the purview of psy-
chiatry arose not primarily from mainstream
psychiatry but from public officials who
wanted to find alternatives to criminal prose-
cution or explicit quarantine. Indeed, the epi-
demic spread during a period when most psy-
chiatric leaders thought psychiatry needed to
narrow its mission, focusing on the diagnosis
and treatment of mental disorders and reject-
ing as “nonmedical” broader social roles pro-
posed for the profession.86 In the years since
AIDS was identified, openly gay psychiatrists
have occupied leadership positions in defining
appropriate roles for psychiatry, lobbied for
increased support for service provision, and
worked to forge alliances between psychiatry
and community-based agencies. More re-
cently, concern over psychiatric coercion has
abated, and there is little reason to believe
that opposition to this social control function
of psychiatry could now be mobilized.
Finally, an argument can be made that a
pure voluntarist position undervalues the cur-
rent benefits to individuals and to public
health. Early detection of HIV can sometimes
function as a substantial prevention interven-
tion, according to a meta-analysis of the ef-
fects of HIV testing on risk behavior.87 Com-
bination antiretroviral treatments can now
reduce viral load and effectively extend peri-
ods of healthy living for many patients.
An important ethical issue is the probable
scope of treatment-related benefits that may
come from testing. If only a few patients with
serious mental illness ultimately benefit from
the new highly active antiretroviral treatments
(HAART), then the loss of autonomy by a
larger group is more difficult to justify. There
are indeed grounds for concern that many pa-
tients with serious mental illness may not be
in a position to benefit. In an August 1998
survey of infectious disease physicians who
treat patients with HIV/AIDS, most said a
patient’s prior psychiatric hospitalization
counts against initiation of HAART.88 This
self-reported reluctance is echoed in a recent
finding that protease inhibitor therapy is initi-
ated later for patients with depression.89 
Caution in the use of HAART is reason-
able, since suboptimal adherence increases
the probability of producing resistant viral
strains, harming the patient’s prospects of suc-
cessful treatment and increasing the danger
that these strains can be spread into the unin-
fected population by patients who continue
risky behavior. Patients who lead socially dis-
organized lives may not be equal to the de-
mands of a complex medication regimen.90
Yet recent data challenge stereotypes regard-
ing the adherence problems of people with
mental illness. One study found that, in a pop-
ulation of Medicaid beneficiaries with HIV,
patients with schizophrenia had higher levels
of antiviral adherence than other patients
with HIV—perhaps because they had previ-
ously been integrated into the care system as
a result of their psychiatric illness.91 While
this example of superior adherence by people
with schizophrenia dates from the pre-
HAART era, recent data suggest that adher-
ence to combination therapies by patients
with schizophrenia is not significantly below
that of other patients.92 (The same study,
however, indicates that patients with recur-
rent major depression or bipolar disorder do
have adherence problems.) A San Francisco
program has recently reported good adher-
ence to protease inhibitor therapy in a sub-
stantial proportion of homeless and margin-
ally housed patients.93
The strongest argument against mandatory
testing proposals for psychiatric patients is the
clear evidence that efforts to promote volun-
tary testing in mental health settings have thus
far been half-hearted and insufficient. Unless
and until more aggressive, systematic, and
well-funded efforts to promote voluntary test-
ing are made, we cannot know if acceptable
levels of HIV detection can be achieved while
the patient’s freedom to choose is upheld.
Specifically, 2 overlapping problems must
be addressed. First, the decision to test for
HIV in this population needs to follow a dif-
ferent logic. The diagnostic approach charac-
teristic of clinical medicine needs to be re-
placed by the logic of screening tests
associated with public health. Rather than
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aiming to determine whether a suspected ill-
ness is present or not, testing should be moti-
vated to identify as many cases as possible,
even when fewer positive results are ex-
pected.57 Second, clinicians tend to overvalue
their own judgment of who is and is not at
risk. Asch and colleagues found that clinicians
treating tuberculosis patients tended to per-
form HIV testing only for patients they per-
ceived to be at risk.94 We believe that, as
among tuberculosis patients, HIV is too prev-
alent among those with serious mental illness
for testing to be instigated by a process as fal-
lible as clinicians’ opinions on a case-by-case
basis. Moreover, when testing proceeds in this
way, infection rates cannot be properly inter-
preted, since they are confounded by un-
known selection factors.
We therefore propose that more strenuous
promotion of voluntary HIV testing programs
such as those proposed by the American Psy-
chiatric Association95 should be pursued by
state mental health authorities and hospital
associations for all psychiatric admissions and
seriously mentally ill individuals seeking or
currently receiving outpatient services. We
know that many people with serious mental
illness currently accept voluntary testing
when it is offered to them.96,97 Various proto-
cols should be specified that rely on existing
behavioral methods such as motivational in-
terviewing, 98 which can reasonably be ex-
pected to yield higher levels of voluntary
testing. Researchers can examine the effec-
tiveness by comparing cases identified by
these protocols with anonymous studies of
discarded blood samples at the same site. Re-
sults could help determine which procedures
produce the fewest missed cases over time.
Advocates and civil libertarians may ques-
tion whether consent can be altogether volun-
tary in psychiatric settings. Inpatients in par-
ticular are subjected to a level of surveillance
and enforced dependency that usually makes
it hard to resist pressure from caregivers,
however delicately applied. Nevertheless, we
believe that, so long as risks and benefits are
understood by patients, confidentiality is pro-
tected, counseling is provided, and infected
patients are guaranteed high-quality HIV
treatment, aggressive promotion of voluntary
testing is not only ethically acceptable, it is
ethically imperative. Certainly, a failure to de-
tect one half to two thirds of cases among in-
patients is unacceptable and justifies concern
for the health of the public. Moreover, on its
face, inadequate detection is inconsistent with
the ethical obligation of health care profes-
sionals to promote the physical well-being of
their patients.
Discussions of mandatory testing are prone
to polarization and the adoption of fixed posi-
tions. Nevertheless, we believe that people
who want to stress one or another of the vari-
ous values at stake can agree that accurate in-
formation on the effectiveness of voluntary
protocols is necessary for any discussion of
policy. The absence of such data leaves citi-
zens with mental illness largely unprotected
from policy initiatives driven by tomorrow’s
tabloid headlines, and leaves the public all
too ready to curtail patients’ rights with little
concern that the sacrifices of these vulnerable
citizens yield proportional benefit.
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